Cardinal Health (NYSE:CAH) Given a $186.00 Price Target at Leerink Partners

Key Points

• Leerink Partners has decreased its target price for Cardinal Health from $188.00 to $186.00, while maintaining an "outperform" rating, indicating a potential upside of 26.95% from its last close.
• Cardinal Health's share price dropped by 7.1% to $146.51 during trading, and the company reported an EPS of $2.08, exceeding analysts' expectations of $2.03.
• The overall consensus among analysts is a "Moderate Buy," with a collective price target averaging $159.93 after various firms issued new ratings and target updates.

Cardinal Health (NYSE:CAH - Get Free Report) has been assigned a $186.00 target price by Leerink Partners in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage currently has an "outperform" rating on the stock. Leerink Partners' target price points to a potential upside of 25.56% from the company's current price.

CAH has been the subject of several other reports. Evercore ISI reiterated an "outperform" rating and set a $180.00 price target (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Finally, Bank of America boosted their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $163.20.

Cardinal Health Stock Performance

Shares of CAH opened at $148.14 on Tuesday. Cardinal Health has a one year low of $105.01 and a one year high of $168.44. The stock has a market capitalization of $35.36 billion, a price-to-earnings ratio of 22.97, a PEG ratio of 1.44 and a beta of 0.67. The stock has a 50 day moving average price of $159.80 and a 200 day moving average price of $144.20.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%. The firm had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The firm's revenue for the quarter was up .5% on a year-over-year basis. On average, analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently bought and sold shares of CAH. Raymond James Financial Inc. purchased a new stake in Cardinal Health in the 4th quarter valued at about $45,115,000. Sterling Capital Management LLC raised its holdings in Cardinal Health by 28.0% in the 4th quarter. Sterling Capital Management LLC now owns 8,201 shares of the company's stock valued at $970,000 after buying an additional 1,796 shares during the period. Townsquare Capital LLC raised its holdings in Cardinal Health by 31.2% in the 4th quarter. Townsquare Capital LLC now owns 4,229 shares of the company's stock valued at $500,000 after buying an additional 1,005 shares during the period. SageView Advisory Group LLC purchased a new stake in Cardinal Health in the 4th quarter valued at about $447,000. Finally, Cohen & Steers Inc. lifted its stake in Cardinal Health by 5.4% during the 4th quarter. Cohen & Steers Inc. now owns 2,281 shares of the company's stock worth $270,000 after acquiring an additional 116 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.